[Increase of oxygen supply for the fetus -- a challenge for the obstetrician and the anesthetist].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A K Luttkus.
Explore the source record for details and available documents.
BACKGROUND: During a study of artificially produced deep hypoxemia in fetal cord blood, systematic errors of three different oxygen saturation analysers were evaluated against a reference CO oximeter. METHODS: The oxygen tensions (PO2) of 83 pre-heparinized fetal blood samples from umbilical veins were reduced by tonometry to 1.3 kPa (10 mm Hg) and 2.7 kPa (20 mm Hg). The oxygen saturation (SO2) was determined (n=1328) on a reference CO oximeter (ABL625, Radiometer Copenhagen) and on three tested instruments (two CO oximeters: Chiron865, Bayer Diagnostics; ABL700, Radiometer Copenhagen, and a portable blood gas analyser, i-STAT, Abbott). The CO oximeters measure the oxyhemoglobin and the reduced hemoglobin fractions by absorption spectrophotometry. The i-STAT system calculates the oxygen saturation from the measured pH, PO2, and PCO2. The measurements were performed in duplicate. Statistical evaluation focused on the differences between duplicate measurements and on systematic instrumental errors in oxygen saturation analysis compared to the reference CO oximeter. RESULTS: After tonometry, the median saturation dropped to 32.9% at a PO2=2.7 kPa (20 mm Hg), defined as saturation range 1, and to 10% SO2 at a PO2=1.3 kPa (10 mm Hg), defined as range 2. With decreasing SO2, all devices showed an increased difference between duplicate measurements. ABL625 and ABL700 showed the closest agreement between instruments (0.25% SO2 bias at saturation range 1 and -0.33% SO2 bias at saturation range 2). Chiron865 indicated higher saturation values than ABL 625 (3.07% SO2 bias at saturation range 1 and 2.28% SO2 bias at saturation range 2). Calculated saturation values (i-STAT) were more than 30% lower than the measured values of ABL625. CONCLUSION: The disagreement among CO oximeters was small but increasing under deep hypoxemia. Calculation found unacceptably low saturation.
Within the last ten years several groups adapted pulse oximetry to be used in the fetus. The obvious advantage of this technology is the fact that a biochemical parameter--the arterial oxygen saturation--can be measured continuously during delivery. Nevertheless, the continuous information about the fetal oxygenation during delivery has a couple of obstacles to surmount. It is well known that fetal reflectance pulse oximetry may be influenced by a number of artifacts. In addition, severe physiological considerations should remind us of the limited diagnostic value of saturation monitoring alone in order to predict fetal acidosis. Some recent articles deal with the predictive value of fetal pulse oximetry for fetal compromise. While it appears that the fetal wellbeing is more likely to be in accordance with a normal saturation measured by current pulse oximetry systems, the number of fetuses detected by pulse oximetry suffering from hypoxia seems to be low. Different authors describe a poor sensitivity to predict fetal compromise. One reason therefore may be the reduced precision of the oxysensor in the low saturation range. Therefore, we conclude that the current generation of fetal pulse oximetry sensors is not improving the quality of combined fetal monitoring of fetal heart rate and fetal scalp blood analysis.
BACKGROUND: The purpose of this study was the correlation of fetal oxygen saturation values to various fetal heart rate patterns, as well as to oxygen saturation values obtained by fetal blood analysis. These objectives need to be evaluated from the perspective that two generations of fetal oxisensors have been used. METHODS: Two different oxisensor systems (FS10: 660+890 nm and FS14: 735+890 nm) and a blinded pulse oximeter (type N400, Nellcor Puritan Bennett) were utilized to monitor 112 fetuses. All data, including oxygen saturation, fetal heart rate patterns, signal and contact quality were stored on a personal computer and evaluated after delivery. RESULTS: The following median fetal oxygen saturation values were obtained: during reassuring fetal heart rate sequences 54% with the oxisensor FS10 and 48% with the newer FS14 oxisensor, during intervals of variable decelerations 43% with the FS10 oxisensor and 40% with the FS14 oxisensor. These differences between values obtained during normal and abnormal fetal heart rate patterns are significant. Due to non-reassuring fetal heart rate patterns 81 fetal blood analyses were performed. The values of pulse oximetry were 9% higher (6% for the FS14) than those of spectrophotometry. Correlation of both methods was r=0.66 (0.74 for the FS14). CONCLUSIONS: In combination with fetal heart rate monitoring, fetal pulse oximetry promises a better differentiation between low and high risk heart rate patterns. Oxygen saturation values from intermittent fetal blood sampling reassure the clinician concerning the accuracy of this new method of intrapartum fetal surveillance and underline the increased quality of the new generation of oxisensor using light of a wavelength of 735 and 890 nm.
OBJECTIVE: To determine whether maternal or fetal morbidity is increased in association with fetal pulse oximetry monitoring using an atraumatic intrapartum transcervical fetal oxisensor. METHODS: In a prospective cohort study from January 1993 to June 1996, 196 fetuses were monitored during the intrapartum period with a fetal oximetry sensor placed between the uterine wall and the presenting fetal part. The oxisensors were in position for a median duration of 134 minutes. A total of 101 monitored fetuses underwent intrapartum fetal scalp blood sampling because of nonreassuring heart rate tracings. For a control group, we selected all cases during the same period in which fetal blood sampling was performed in the intrapartum period (n = 949) without pulse oximetry monitoring. Data for maternal and fetal morbidity were evaluated and tested for significant differences by the Mann-Whitney U test. RESULTS: There was no significant difference in gestational age, birth weight, duration of labor, fetal outcome parameters, cesarean rate, operative vaginal deliveries, episiotomy rate, or perineal injuries between the study and control groups. Similarly, the percentages of neonatal intensive care unit admissions, neonatal resuscitations, and neonatal infections were not statistically different in the two groups. A rare complication in the group with pulse oximetry monitoring was a transient impression of the oxisensor probe on the fetal cheek. The rates of postpartum maternal infections, anemia, or secondary wound disruptions were identical in both groups. CONCLUSION: There was no increased fetal or maternal morbidity associated with the use of an atraumatic intrapartum fetal pulse oxisensor.
Fetal pulse oximetry provides a tool for the surveillance of the fetus at risk of hypoxia. The experience of 150 deliveries monitored by pulse oximetry and the analysis of data may allow preliminary recommendations for clinical use in cases of suspected fetal hypoxia based on a suspicious FHR. In most cases, saturation values above 33% suggest fetal well-being. Further fetal evaluation, for example by fetal blood samples or other means, is necessary to assess alterations of FHR pattern or decreases in saturation values. Pulse oximetry may allow a differentiation between cases that need further evaluation, such as scalp blood sampling, and those which do not. The number of repeated assessments may be reduced as long as the oxygen saturation and FHR pattern do not worsen. The effect of therapeutic measures on fetal oxygenation can be directly observed. The positive preliminary experiences with fetal pulse oximetry predominate even if high expectations of easy detection of fetal hypoxia have so far not been fulfilled.